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Welcome Address: Dr. V. Costigliola, President of EPMA  
Educational Symposium 
“Inflammation and Autoimmunity: 
Risk Assessment and Predictive Approaches 
through the Analytical Armamentarium” 
Lecture Hall A, 1 pm - 3:30 pm 
 
Chairmen: Prof. Dr. S. Suchkov 
   Prof. Dr. T. Marshall 
 
Brief Opening Ceremony       1.00 pm 
Prof. Dr. S. Suchkov 
The I.M.Sechenov First Moscow State Medical University and 
Moscow State Medical & Dentistry University, Russia 
 Introductory: The concept of predictive, preventive 
     & personalised medicines as the concerted players in  
      the advanced healthcare      1.05 pm 
Prof. Dr. O. Golubnitschaja 
University of Bonn, Germany 
Secretary-General, European Association for Predictive,  
Preventive and Personalised Medicine, EPMA, Brussels, Belgium 
 Predictive Medicine as being Illustrative: Antibodies   1.30 pm 
as Tools to challenge for The New 
Prof. Dr. S. Suchkov 
The I.M. Sechenov First Moscow State Medical University and 
Moscow State Medical & Dentistry University, Russia 
Prof. Dr. A. Notkins 
NIH, Bethesda, MD, USA 
 
Predictive Medicine as being Illustrative: Interplay   2.00 pm 
between Microbiome and the Host's Immunity as a 
Factor to be used for Prediction 
Prof. Dr. T. Marshall 
Murdoch University of Western Australia 
 
“Round-table” discussion       2.30 pm 
 
Setting up a Section of the EPMA for young    3.00 pm 
researchers, clinicians and medical students 
Prof. Dr. O. Golubnitschaja 
University of Bonn, Germany 
Secretary-General, EPMA 
 
Closing         3.30 pm 
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 Posters related to the topic: 
 
Features of the innate and adaptive immunity in patients with intracranial infectious and inflammatory 
diseases.   
M. Sautin1, N. Cherepakhina2, T. Bodrova3, S. Suchkov2 
1Peoples’ Friendship University of Russia, Moscow, Russia; 2I.M. Sechenov First Moscow State Medical 
University, Moscow, Russia; 3Higher School of Economy, Moscow, Russia 
 
Post-infectious clinical-immunological syndrome and its role in the state-of-the-art model of 
immunopathogenesis of chronic infectious diseases. 
M.M Agirov2,5, J.A. Tabaksoeva2, K.A.  Akhmedilova2, N.E. Cherepakhina1,3, Z.S. Shogenov2, T.A. Bodrova4, 
S.V.Suchkov1,2 
1I.M. Sechenov First Moscow State Medical University (FMSMU), Moscow, Russia; 2Russian State Medical 
University (RSMU), Moscow, Russia; 3Federal Agency of Medical and Biological Problems under the 
Government of the Russian Federation, Moscow, Russia; 4Department of Economy of Health Services, The 
Higher School of Economy, Moscow, Russia; 5University of World Politics and Law, Faculty of Economy of 
Medical Technologies, Moscow, Russia 
 
Antithyroid autoantibody population as a source of antibody specificity and functionality: clinical 
significance of the phenomenon of the serological orchestra in monitoring of patients with Graves' disease. 
Z.I. Bogatyreva1, A.V. Andreeva, E.N. Suchkova, A.L. Notkins, S.V. Suchkov 
1University of World Politics and Law, Faculty of Economy of Medical Technologies, Div of Endocrinology, 
Municipal Clinical Hospital №81, Moscow, Russia; 2Department of Endocrinology, AGMA and Alexandro-
Mariinskay Clinical Hospital, Astrakhan, Russia; 3Dept of Endocrinology and Diabetology, and the Dept of 
Clinical Immunology, MGMSU, Moscow, Russia; 4National Institutes of Health, Bethesda, MD, USA 
 
Associative correlation between clinical manifestations of PICIS and CRID: modern trends in the pre-
early diagnostics. 
K.A. Akhmedilova2, M.M. Agirov2, J.A. Tabaksoeva2, N.E. Cherepakhina1,3, T.A. Bodrova4, Z.S. Shogenov2, 
S.V.Suchkov1,2 
1I.M. Sechenov First Moscow State Medical University (FMSMU), Moscow, Russia; 2Russian State Medical 
University (RSMU), Moscow, Russia; 3Federal Agency of Medical and Biological Problems under the 
Government of the Russian Federation, Moscow, Russia; 4Department of Economy of Health Services, The 
Higher School of Economy, Moscow, Russia  
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Welcome Address: Prof. Dr. O. Golubnitschaja,  
Secretary-General of EPMA 
 
Individualised Nutrition in Preventive and 
Personalised Medicine 
 
Lecture Hall B, 1 pm – 3:30 pm 
 
Chairman: Prof. Dr. G.M. Trovato, University of Catania, Italy 
 
Speakers: 
 Prof. Dr. I. Huybrechts, Faculty of Medicine, Ghent University. Food intake of 
European adolescents. Guidelines, adherence and compliers’ biomarkers. 
 Dr. J. Twigt, Erasmus University Medical Center, Rotterdam, The Netherlands. 
Preconception nutritional and lifestyle counseling applied in a tertiary clinical 
setting, uptake of advice and the association with IVF/ICSI treatment outcomes. 
 Prof. Dr. G. Carruba, Department of Oncology, ARNAS-Civico, Palermo, Italy. A 
traditional Mediterranean diet changes metabolic profiles of endogenous 
hormones and reduces cancer risk: the evidences. 
 Prof. Dr. P. Toniolo, Division of Epidemiology, Obs-Gyn, NY School of Medicine, 
NY University, New York, USA. Nutrition and cancer trends. 
 Prof. Dr. D. Catalano, University of Catania, Italy. Tailored dietary prescription 
and Clustering of Clinical training, skills and expertise. 
 Dr. F. M. Trovato, University of Catania, Italy. Dietary profile and physical activity 
assessment: a step toward a personalized approach. 
 Dr. C. Pirri, University of Catania, Italy. Nutritional EBM approaches in the most 
common challenges and disease. 
 Dr. N. Shapira, Medical & Functional Nutrition, R&D Foods & Diets, Institute for 
Nutrition Research, Rabin Center, Beilinson Hospital. Petach-Tikva, Israel. Higher 
women risk vs. men's advantage with high Omega-6 PUFA intake: a gender 
paradox hypothesis 
 
 
 
Panel Discussion 
Moderator: Prof. Dr. G.M. Trovato, University of Catania, Italy 
 
Closing remarks:  Prof. Dr. G.M. Trovato, University of Catania, Italy. The need of  
 nutritional paradigms and the use of e-learning tools in Medical  
 Curricula and Training 
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 EPMA / Springer 
 
Education in Predictive, Preventive  
and Personalised Medicine 
 
Lecture Hall A, 4 pm – 6 pm 
 
 
Chairmen: Dr. V. Costigliola, President of EPMA  
  Dr. P. Butler, Editorial Director, Biomedicine, Springer 
 
Speakers: 
 Dr. P. Butler, Editorial Director, Biomedicine, Springer 
 Dr. M. Roelandse, Associate Editor, Biomedical Unit, Springer 
 Dr. M. Karlikova, Charles University in Prague, Medical Faculty in Pilsen, Czech 
Republic 
 
 
Panel Discussion 
 
Moderator: Prof. Dr. O Golubnitschaja, Editor-in-Chief, The EPMA J. & Book-Series 
“Advances in PPPM”, EPMA / Springer 
 
Panellists: 
 Prof. Dr. M. Mozaffari, Associate Editor, The EPMA J. & Book-Series “Advances in 
PPPM” 
 Dr. S. Mandel, Associate Editor, The EPMA J. & Book-Series “Advances in PPPM” 
 Prof. Dr. D. Desiderio, Associate Editor, The EPMA J. 
 Prof. Dr. H. Iso, Associate Editor, The EPMA J. 
 Prof. Dr. M. Scarpa, Associate Editor, The EPMA J. 
 Prof. Dr. O. Topolcan, Charles University in Prague, Medical Faculty in Pilsen, Czech 
Republic 
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2nd Congress-Day, September 16th, Friday 
 
Venue: Parliament of Federal Republic of Germany – Bundeshaus 
Platz der Vereinigten Nationen 2 
 
Congress Opening Ceremony  
9am – 9:20am 
 
Welcome Address:  
 Congress Organisers –     Prof. Dr. O. Golubnitschaja  
Dr. V. Costigliola   
 
 Lord Mayor of Bonn –     Mr. J. Nimptsch 
 
 Rector of the University of Bonn –   Prof. Dr. J. Fohrmann 
 
Specialised Sessions 
 
Healthcare in overview across the globe 
 
9:30 am – 12:00 am 
 
 Lunch: 12am – 1pm 
Chairman: Prof. Dr. O. Golubnitschaja, Secretary-General of EPMA 
 Speakers: 
 Prof. Dr. F. Paul, National Representative of EPMA in Germany 
 Dr. K. Grosios, National Representative of EPMA in UK 
 Prof. Dr. H. Iso, National Representative of EPMA in Japan 
 Dr. M. Kapalla, National Representative of EPMA in Slovak Republic 
 Prof. Dr. K. Richter, National Representative of EPMA in Macedonia 
 Dr. D. Dimitrov, National Representative of EPMA in Bulgaria 
 Prof. Dr. M. Dündar, National Co-Representative of EPMA in Turkey 
 Panel Discussion 
Moderator: Dr. V. Costigliola, President of EPMA 
 
Panellists:  
 Dr. A. Benini, Missionary of the Organisation of United Nations 
 Dr. R. Maksimovic, Missionary of the World Health Organisation 
 Dr. P. Bilinski, Chief of Sanitary Inspector responsible for public health in Poland 
 Mr. A. Prakash, Minister of Health, Kerala State, India 
 Prof. Dr. S. Suchkov, on behalf of Government, Russia 
 Prof. V. Paunescu, the Presidency health politics counsellor, Romania 
EPMA Journal (2011) 2 (Suppl 1):S37–S66 S43
  
National & International Granting Strategies in PPPM  
Innovative Programmes 
Economy of Personalised Medicine 
 
1 pm – 2:20 pm 
 
Chairman: Prof. Dr. O. Golubnitschaja 
 
Speakers: 
 Prof. Dr. M. Goldman, Director, Innovative Medicines Initiative, EU-Commission, 
Brussels, Belgium 
 Dr. C. Longson, Director, National Institute for Health & Clinical Excellence, UK 
 Dr. L. Kristiansen, Medical Sciences, European Science Foundation, Strasbourg, 
France 
 Prof. Dr. Paltsev, Vice-Director of the I. Kurchatov National Center for Science and 
Technologies, Russia  
 Dr. J. Greuel, Adjunct Professor of Finance & Healthcare Management IE Business 
School, Madrid, Spain / Managing Director, Bioscience Valuation BSV GmbH, 
Germany 
 
Panel Discussion 
Moderator: Prof. Dr. M. Ferrari, President of EUSPM 
 
Panellists:  
 Dr. J.-L. Sanne, Directorate for Personalised Medicine, EU-Commission, Brussels, 
Belgium 
 Prof. A. Streinu Cercel, Ministry Secretary of State, Ministry of Health, Romania 
 Speakers  
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Patient Needs 
Challenges for Stakeholders  
in Predictive, Preventive & Personalised Medicine 
2:30 pm – 4:00 pm 
 
Chairman: Prof. Dr. M. Scarpa, “Brains for Brain” Research Foundation 
 
Speakers:  
 Mr. M. Hadder, NRW-Representative, German Federation of Diabetics, Germany 
 Mr. J. Bowis, President of Health First Europe, Vice-President of the  
      European Health Forum Gastein, Chairman of the Health Advisory Board of   
      GlaxoSmithKline 
     
Panel Discussion 
 
Moderator: Dr. G. Vittadini, Director of Technology Opportunities, Bracco Imaging  
 
Panellists:  
 General Practitioners: Dr. V. Costigliola, President of EPMA  
     Dr. J. Mendive, National EPMA-Representative in Spain 
 ESR: Prof. Dr. M. Reiser, past President of ESR, Dean of the Medical Faculty,  
      Ludwig Maximilians University Munich, Germany 
 Industry: Dr. A. Jansen, Director, DiaDexus       
 Insurance: Dr. L. Duta, the National Insurance House President, Romania  
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Innovative PPPM-Centres 
Overall Concept 
Medical Imaging for Disease Prediction and Prevention   
Innovative Diagnostic Tools 
New Perspectives in Healthcare 
4:10 pm – 5:20 pm 
 
Chairman: Prof. Dr. G. Frija, Hopital Européen Georges Pompidou in Paris, France,  
 Vice-President of the European Society of Radiology 
 
Speaker:  
Prof. Dr. G. P. Krestin, Erasmus MC, University Medical Centre Rotterdam, The Netherlands; 
Vice-President of the European Society of Radiology 
     
 
Panel Discussion 
 
Moderator: Prof. Dr. O. Golubnitschaja, Molecular Diagnostics, University of Bonn,  
                     Germany 
 
Panellists:  
 General practitioners: Dr. V. Costigliola, Brussels, Belgium  
 Laboratory Medicine: Dr. M. Pelsers, “Laboratory Stein GmbH”, Germany 
 Bioinformatics: Dr. M. Kapalla, Faculty of Medicine, Comenius University, 
Bratislava, Slovakia; Negentropic Systems, s.r.o, Ruzomberok, Slovakia 
 Medical Imaging: Prof. Dr. G. Krestin, Prof. Dr. G. Frija, the European Society of 
Radiology 
 Innovative molecular diagnostic tools:  
   Prof. Dr. Ch. Gerner, Cancer Proteomics, University of Vienna, Austria 
   Dr. Th. Joos, NMI, Germany 
   Dr. K. Krapfenbauer, Boehringer Ingelheim, Vienna, Austria  
   Dr. P. Schulz-Knappe, Protagen GmbH, Germany 
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Education  
in Predictive, Preventive & Personalised Medicine: 
Challenges 
Innovative Programmes 
Didactic Materials 
5:30 pm – 6:30 pm 
 
Chairman: Prof. Dr. H.H. Schild, Head of the Radiological Clinic, University of Bonn,  
 Germany 
 
Speakers:  
 Dr. J. Delgado, Head of Unit Vocational Education and Training Policy, Leonardo da 
Vinci Programme, EU-Commission, Brussels, Belgium 
 Dr. P. Butler, Editorial Director, Biomedicine, Springer 
 
Panel Discussion 
 
Moderator: Prof. Dr. O Golubnitschaja, Editor-in-Chief, The EPMA J. & Book-Series 
“Advances in PPPM”, EPMA / Springer 
 
Panellists: 
 Dr. V. Costigliola, Associate Editor, The EPMA J. & Book-Series “Advances in 
PPPM”  
 Prof. Dr. M. Mozaffari, Associate Editor, The EPMA J. & Book-Series “Advances in 
PPPM” 
 Dr. S. Mandel, Associate Editor, The EPMA J. & Book-Series “Advances in PPPM” 
 Prof. Dr. D. Desiderio, Associate Editor, The EPMA J. 
 Prof. Dr. H. Iso, Associate Editor, The EPMA J. 
 Prof. Dr. M. Scarpa, Associate Editor, The EPMA J. 
 Prof. Dr. O. Topolcan, National Representative of EPMA in Czech Republic 
 
 
 
 
 
Congress dinner: Rhine-river cruise, 7pm – 10pm 
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 3rd Congress-Day, September 17th, Saturday  
Venue: University Bonn, Poppelsdorf, Nußallee 10 
 
Specialised Session 
 
Predictive, Preventive and Personalised Medicine in Cancer 
Lecture Hall A 
 
9:00 am - 12:00 am 
Chairmen:  Prof. Dr. D. Desiderio, University of Tennessee Health Science Center,  
 Memphis, USA 
  Prof. Dr. D. Characiejus, Medical Faculty, Vilnius University, Lithuania 
Keynote Speakers: 
 Prof. Dr. D. Characiejus, Medical Faculty, Vilnius University, Lithuania. "First Do 
No Harm" and the Importance Of Prediction in Oncology. 
 Dr. X. Zhan, University of Tennessee Health Science Center, Memphis, USA. The 
Use of Variations in Proteomes to Predict, Prevent, and Personalize Treatment 
for Clinically Nonfunctional Pituitary Adenomas. (awarded article, The EPMA J.) 
 Dr. Ch. Swanton, Translational Cancer Therapeutics Laboratory, London, UK. 
Personalised treatment approaches in cancer.  
Short oral presentations: 
 Dr. M. Mallmann, University of Bonn, Germany, Prediction and Prognosis in 
Breast cancer. (awarded article, The EPMA J.) 
 Prof. Dr. Ch. Gerner, Department of Medicine I, Medical University of Vienna, 
Vienna, Austria. Early cancer diagnosis and novel therapeutic options resulting 
from systematic proteome profiling of tumour-associated stroma cells. 
 Dr. A. González Neira, Spanish National Cancer Research Centre (CNIO), Madrid, 
Spain, EPMA-Spain. Pharmacogenomics in Cancer Therapy 
 Prof. Dr. U. Rovigatti, University of Pisa, Italy. PPPM Early in Life: Molecular and 
Epidemiological Models from Paediatric Cancer. 
 Dr. E.  Moiseeva, Institute of Bioorganic Chemistry, Moscow, Russian Federation. 
Towards Personalised Paradigm of Experimental Anticancer Research With 
“3S” Concept 
 Prof. Dr. M. Pesta, Department of Internal Medicine, Faculty of Medicine in Pilsen, 
Charles University in Prague, Czech Republic; Prognostic significance of miR-21 
and miR-143 expression in tissue samples of Colorectal Carcinoma and 
Colorectal liver metastases.  
 Dr. S. Kovalenko, Institute of Molecular Biology and Biophysics, Novosibirsk, 
Russia, VNTR at HER2/neu Gene Amplification Border in Breast Cancer – the 
“Weakest Link” in Gene Amplification?  
Panel Discussion 
 
Moderator: Prof. Dr. L. Berliner, Weill Cornell Medical College of Cornell University, New 
York, USA   
Panellists: 
Prof. Dr. R. Danesi, University of Pisa, Italy 
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Speakers 
 
Poster Overview: Dr. S. Hagan, Glasgow Caledonian University, Scotland, Editorial 
BOARD, The EPMA J. 
 
Posters related to the topic: 
 
Identification of Calponin-h2 as potential serum-based marker for the early diagnosis of breast cancer. 
M. Debald1, S. Franken2, L.C. Heukamp3, A. Linke4, M. Wolfgarten1, K.-J. Walgenbach1, C. Rudlowski1, S. 
Holdenrieder4, M. Braun1, G. Hartmann4, W. Kuhn4, G. Walgenbach-Brünagel4 
1Department of Obstetrics and Gynecology, Centre for Integrated Oncology,  University of Bonn, Germany; 
2Institute for Biochemistry and Molecular Biology, University of Bonn, Bonn; 3Institute of Pathology, Centre for 
Integrated Oncology,  University of Bonn, Germany; 4Institute for Clinical Chemistry and Clinical 
Pharmacology, Centre for Integrated Oncology, University of Bonn, Germany 
 
Vitamin D and Cancer Diseases. 
R. Fuchsova, O. Topolcan, P. Pazdiora, S. Svobodova, J. Vrzalova, G. Krakorova, M. Spisakova, V. Treska, I. 
Treskova, M. Pesek, J. Finek 
Faculty Hospital and Medical Faculty in Pilsen, Charles University, Czech Republic 
 
Multiplex panel for ovarian carcinoma. 
J. Vrzalova1,3, O. Topolcan1,3, Z. Novotny2, J. Presl2, M. Pesta3 
1Immunoanalytic Laboratory, Dep. of Nuclear Medicine, Faculty Hospital in Pilsen; 2Dep. of Gyneacology, 
Faculty Hospital in Pilsen, Czech Republic; 3Central Isotopic laboratory, Fac. of Medicine in Pilsen, Charles 
University in Prague, Czech Republic 
 
Cancer-associated immune-mediated syndromes: Pathogenic values and clinical implementation. 
A.M. Merkulova1, A.V. Kostalevskaya1, S.V. Suchkov1,2 
1I.M. Sechenov First Moscow State Medical University, Moscow, Russia; 2Moscow State Medical Dentistry 
University, Moscow, Russia 
 
Incorporation of National Cancer Control Plane in Georgian Health Care System. 
M. Maglakelidze, N. Jokhadze, T. Rukhadze, R. Gagua 
National Cancer Center of Georgia, Association of Oncologists of Georgia 
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 Specialised Session 
 
Predictive Diagnostics and Personalised Medicine in Paediatrics 
THE MODEL OF NEURODEGENERATIVE DISORDERS 
Lecture Hall B 
 
9:00 am - 12:30 am 
 
9:00 –9.20 Prof. Dr. M. Scarpa, Prof. Dr. D. Begley UK, Chairmen  
 
Keynote Lecture 
 
• Mr. J. Bowis, OBE, UK. Brain, rare neurological diseases and European health 
care systems.  
 
9.20 – 10.00 Theme 1 – Personalised Medicine for Brain Rare Diseases: The family 
expectation   
• Mr. J. Green and B. Owen,  Niemann Pick C International Association. Living with a 
person affected by a rare disease: impact on the family and carers  
• Mrs. M. Baker, MBE – President EFNA. Promoting awareness  brain diseases in 
Europe: enabling the dialogue between science and society to prevent, predict, 
personalise the Medicine 
• Dr. G. Tsangaris, Greece, Biomedical Research Foundation, Academy of Athens. 
Medical science and prevention of paediatric diseases. 
  
10.00-11.15 Theme 2 – Paediatric Personalised Medicine and Brain Rare diseases: The 
science effort  
 
• Prof. Dr. O. Golubnitschaja, Secretary-General EPMA, Germany. Birth asphyxia as 
the major complication in newborns: Moving towards improved individual 
outcomes by prediction, targeted prevention and tailored medical care.  
• Prof. R. Haseloff, Germany. Prediction of Neurodegenerative disorders: The 
search for biomarkers. 
• Prof. F. Platt, UK. Understanding pathogenesis: fundamental insights and new 
therapeutic opportunities. 
• Prof. A. Ceci, Italy. The right therapy for the patients at the right moment: the 
scientist perspective  
• Dr. N. Barton, SHIRE. The right therapy for the patient at the right moment: the 
Biotech effort.  
  
11.30-12.00 Discussion  
 
12.00-12.20 keynote lecture  
• Prof. T. Cox, UK. The burden of neurological diseases of childhood in Europe: 
what is the future? 
   
Poster Overview: Prof. Dr. T. Rukhadze, University of Tbilisi, Georgia, Editorial BOARD, 
The EPMA J.  
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Closing remarks  
 
 
 
 
 
Posters related to the topic: 
 
Drugs may contribute oral-facial clefts in newborn baby. 
N. Velickova, M. Gacova, N. Kamcev, B. Angelovska, C. Dimova 
Faculty of medical science University “Goce Delcev” – Stip 
 
Comparative study of allele frequencies of PAI-1, MTHFR, FV, FI and GpIIIa gene polymorphisms in 
children with Henoch–Schönlein purpura, Schamberg Disease and healthy children. 
N.V. Shirinbekova, E.V. Voronina, A.N. Voitovich, V.I. Larionova 
St. Petersburg State Pediatric Medical Academy, St. Petersburg, Russia 
 
Anti-Streptolysin O (ASO) titer and anti-basal ganglia antibodies (ABGA) in a large cohort of Tourette 
patients: possible perspective of more targeted preventive and therapeutic approaches. 
R. Rizzo1, F. Chiarotti2, M. Buttiglione3, F. Cardona4, M. Gulisano1, N. Nardocci5, G. Orefici2, E. Veneselli6, F. 
Vitiello3, D. Martino8 
1Child and Adolescent Neuropsychiatry,  Materno-Infantile and Radiological Sciences Department, University of 
Catania, Italy; 2Istituto Superiore di Sanità, Rome, Italy; 3Dept. of Human Pharmacology and Physiology, Univ. 
of Bari, Italy; 4Department of Child and Adolescent Neuropsychiatry, University of Rome “La Sapienza”, Rome, 
Italy; 6Besta Neurological Institute, Milan, Italy; 7Istituto G. Gaslini, Genoa, Italy; 8Dep.of Neurol. And ,Psych. 
Sciences, Univ. of Bari, Italy 
The personalized approach to drug dosing of Valproic Acid at women with epilepsy, who are carriers of 
mutations of Folate Cycle Genes. 
D. Dmitrenko, M. Pilugina, N. Shnayder 
Krasnoyarsk State Medical University named after Prof. V.F. Vojno-Jasenetsky, Krasnoyarsk, Russia 
 
 
 
Lunch: 12 am – 1 pm 
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 Specialised Session 
 
Predictive, Preventive and Personalised Medicine  
in Cardiovascular Diseases 
 
Lecture Hall A 
 
1 pm – 3:45 pm 
Chairmen: Prof. Dr. H. Iso, Osaka University, Japan 
   Prof. Dr. P. Evans, British Heart Foundation, Imperial College London, UK  
Keynote Speakers: 
 Prof. Dr. H. Iso, Osaka University, Japan. PPPM in Cardiovascular Pathologies: 
Japanese health success in combating cardiovascular diseases. 
 Prof. Dr. P. Evans, British Heart Foundation Cardiovascular Sciences Unit, National 
Heart and Lung Institute, Imperial College London, UK. The influence of 
Sulforaphane on vascular health and its relevance to nutritional approaches to 
prevent Cardiovascular Disease. 
 Prof. Dr. H. Rosolova, Charles University in Prague, Medical Faculty in Pilsen, Czech 
Republic, Cardio-metabolic risk prediction should be superior to cardiovascular 
risk assessment in primary prevention of Cardiovascular Diseases. 
 Prof. Dr. J. Kastrup, The Heart Centre, Rigshospitalet University Hospital 
Copenhagen, Denmark. Stem cells therapy for cardiovascular repair in ischemic 
heart disease: How to predict and secure optimal outcome? 
 Dr. A. Jansen, DiaDexus. Cardiovascular risk assessment: view of industry. 
 Short oral presentations: 
 Dr. H Yatsuya, Department of Public Health, Nagoya University Graduate School of 
Medicine, Japan. Adiposity and cardiovascular disease risk in Japan: --
implications to public health screening program of obesity for the prevention of 
cardiovascular disease. 
 Dr. Y. Kokubo, Department of Preventive Cardiology, National Cerebral and 
Cardiovascular Center, Osaka, Japan. Associations of impaired glucose metabolism 
and dyslipidemia with cardiovascular disease: What have we learned from 
Japanese cohort studies for individualized prevention and treatment?  
 Dr. K. Yamagishi, University of Tsukuba, Tsukuba, Japan. N-terminal fragment of 
the prohormone brain-type natriuretic peptide (NT-proBNP) and cardiovascular 
risk factors amongst Japanese population: The Circulatory Risk in Communities 
Study.  
 Prof. Dr. J. Polivka, Faculty of Medicine of Charles University, Czech Republic. 
Optimisation of Stroke Care in Concept of Predictive, Preventive and 
Personalised Medicine. 
 
Panel Discussion 
 
Moderator: Prof. Dr. Ch. Gluud, Copenhagen University Hospital, Copenhagen, Denmark; 
Danish National Coordinator, ECRIN. 
 
Panellists: 
 Dr. E. Jorgensen, Copenhagen University Hospital, Copenhagen, Denmark 
 Speakers 
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Poster Overview: Dr. A. Benini, University Copenhagen, Denmark, Editorial BOARD, The 
EPMA J. 
 
 
Posters related to the topic: 
 
The effect of Perindopril on Endothelin and Nitric Oxide Production and Circadian alteration of 
Cardiovascular Indicis in hypertensive rats. 
T.Kezeli1, N. Gongadze2, G. Sukoian1, N. Dolidze1, T. Rukhadze1 
1Department of Pharmacology, Faculty of Medicine, State University; 2Department of Pharmacology, State 
Medical University, Tbilisi, Georgia 
 
AHSG gene polymorphism affects plasma levels of non-high-density lipoprotein cholesterol in Caucasians. 
P. Suchanek1,2, J.A. Hubacek1,2, I. Kralova Lesna1,2 
1Institute for Clinical and Experimental Medicine, Prague, Czech Republic; 2Cardiovascular Research Centre, 
Prague, Czech Republic 
 
The effect of the supplementation omega 3 fatty acids to lipids and anthropometric parameters in the 
obese young volunteers. 
P. Suchanek1,2, J.A. Hubacek1,2,3, I. Kralova Lesna1,2, V. Pinekerova1, R. Stupalova1, N. Stankova1 
1Institute for Clinical and Experimental Medicine, Prague, Czech Republic; 2Centre for Cardiovascular Research, 
Prague, Czech Republic, 3South Bohemia University, Faculty of Public Health and Social Studies, Ceske 
Budejovice, Czech Republic 
 
Large Vessel Aneurisms in the Era of Genomics and Proteomics:  Horizons of Predictive Medicine. 
D.I. Cherepakhin4, Yu.V. Belov1, E. Charchyan1, S.V. Suchkov2,3 
1B.V. Petrovsky Russian Research Center for Surgery (RRCS), Russian Academy of Medical Sciences, Moscow, 
Russia; 2I.M. Sechenov First Moscow State Medical University, Moscow, Russia; 3Moscow State Medical 
Dentistry University (MSMDU), Moscow, Russia; 4N.I. Pirogov Russian State Medical University (RSMU), 
Moscow, Russia 
 
Predictive testing of thrombophilia-related genetic variations in the Czech population. 
M. Koudová, R. Vlčková, M. Bittóová, M. Majer, I. Slepičková, E. Lavická, M. Hlaváčová, G. Izrael, V. 
Indráková, J. Karas 
GHC Genetics, s.r.o. - Private Medical Facility, Prague, Czech Republic 
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 Specialised Session 
 
Predictive, Preventive and Personalised Medicine  
in Neurodegenerative Diseases 
 
Lecture Hall B 
 
1 pm – 3:45 pm 
Chairmen: Dr. S. Mandel, Technion, University of Haifa, Israel 
  Prof. Dr. A. Tasker, University of PEI, Prince Edward Island, Canada 
 
Speakers: 
 Prof. Dr. G. P. Krestin, Erasmus MC, University Medical Centre Rotterdam, The 
Netherlands. Application of imaging in prediction, prevention and treatment 
monitoring of neurodegenerative diseases. 
 Dr. S. Mandel, Eve Topf Center for Neurodegenerative Diseases Research and 
Department of Molecular Pharmacology, Faculty of Medicine, Technion, Haifa, Israel. 
Biomarkers for Prediction and Targeted Prevention of Alzheimer's and 
Parkinson's Diseases: Evaluation of Drug Clinical Efficacy. (awarded article, The 
EPMA J.) 
 Dr. I. Grossman, Cabernet Pharmaceuticals, USA, Alzheimer’s disease: diagnostics, 
prognostics and the road to prevention. (awarded article, The EPMA J.) 
 Prof. Dr. A. Tasker, Department of Biomedical Sciences, University of Prince Edward 
Island, Canada. New animal models of progressive neurodegeneration: tools for 
identifying presymptomatic therapeutic targets. 
 
Short oral presentations: 
 Dr. O. Weinreb, Eve Topf Centers of Excellence for Neurodegenerative Diseases 
Research, Rappaport Family Research Institute, Israel. Technological Aspects of 
Personalized Approaches in Treatment of Amyotrophic Lateral Sclerosis. 
(awarded article, The EPMA J.) 
 Dr. K. Yeghiazaryan, Molecular Diagnostics, Department of Radiology, University of 
Bonn, Germany Key molecular pathways affected by glaucoma pathology: Is 
predictive diagnosis possible? (awarded article, The EPMA J.) 
 Prof. Dr. F. Paul, Charité Berlin, Germany, The role of optical coherence 
tomography in predicting and monitoring disease activity in MS. 
 
Panel Discussion 
Moderator: Dr. I. Grossman, Cabernet Pharmaceuticals, USA  
 
Panellists:  
 Prof. Dr. L. Spiru, President "Ana ASLAN" International Foundation, Bucharest, 
Romania 
 Prof. Dr. D. Muresanu, President of the Society for the Study of Neuroprotection and 
Neuroplasticity (SSNN), Romania 
 Speakers 
 
Poster Overview: Prof. Dr. F. Paul, Charité Berlin, Germany, Editorial BOARD, The EPMA 
J. 
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Coffee break: 3:45 – 4:15 pm 
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 Specialised Session 
 
Predictive, Preventive and Personalised Medicine  
in Diabetes Care 
 
Lecture Hall A 
 
 
4:15 pm – 7:00 pm 
Chairmen:  Prof. Dr. M. Mozaffari, Georgia Health Sciences University, Augusta, Georgia, 
 USA 
 Prof. Dr. T. Josifova University Hospital Basel, Eye Clinic, Switzerland 
Speakers: 
 Dr. C. Sena, Medical Faculty, University of Coimbra, Portugal. Potential new 
strategies in Diabetes therapeutics. (awarded article, The EPMA J.) 
 Dr. W. Abebe, Georgia Health Sciences University, Augusta, Georgia, USA, 
Endothelial dysfunction in diabetes: potential application of circulating markers 
as advanced diagnostic and prognostic tools. (awarded article, The EPMA J.) 
 Prof. Dr. T. Josifova, University Hospital Basel, Eye Clinic, Switzerland Visual Loss 
in Diabetic Patients – do we prevent it or do we treat only the complications?  
 Dr. S. Li Calzi, University of Florida, USA, Endothelial progenitor dysfunction in 
the pathogenesis of diabetes retinopathy: treatment concept to correct diabetes-
associated deficits. (awarded article, The EPMA J.)  
 Prof. Dr. J. Coelho, Department of Chemical Engineering, University of Coimbra, 
Portugal. Drug delivery systems: Advanced technologies potentially applicable in 
personalized treatments. (awarded article, The EPMA J.) 
 
Short oral presentations: 
 Dr. R. Krishna, Department of Periodontics, College of Dental Medicine, Augusta, 
USA. Characteristics of inflammation common to both diabetes and 
periodontitis: are predictive diagnosis and targeted preventive measures 
possible? 
 M.Sc. M. Cebioglu, Molecular Diagnostics, Department of Radiology, University of 
Bonn, Germany. Cancer predisposition in Diabetes: Risk factors considered for 
predictive diagnostics. (awarded article, The EPMA J.)  
 Prof. Dr. B. Baban, College of Dental Medicine, Georgia Health Sciences University, 
Augusta, Georgia, USA. Inflammatory markers as potential predictive indicators 
for diabetic nephropathy. 
 Dr. D. Dimitrov, National Representative of EPMA in Bulgaria. Bariatric Medicine: 
Multidisciplinary approach for obesity prevention. 
 Prof. Dr. V. Larionova, Russia, St. Petersburg State Paediatric Medical Academy, 
Saint-Petersburg, Russia. Polymorphic genetic markers are of significance in 
developing of the diabetes mellitus type II in metabolic syndrome patients.   
 
Panel Discussion 
Moderator: Prof. Dr. L. Salminen, Ophthalmologic Clinic, University of Tampere, Finland, 
National Representative of EPMA in Finland 
 
Panellists: Speakers 
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Poster Overview: Prof. Dr. J. Coelho, Department of Chemical Engineering, University of 
Coimbra, Portugal, Editorial BOARD, The EPMA J. 
 
Posters related to the topic: 
 
Ankle – brachial index in type 2 diabetes patients and cardiovascular risk. 
B. Nussbaumerova, H. Rosolova, F. Sefrna, I. Sipova, P.Sifalda 
2nd Medical Department, Charles University in Prague - Medical Faculty in Pilsen, Czech Republic 
 
Measurement of Angiogenesis Promotors and Cytokines Concentrations in Intraocular Fluid of 
Patients with Proliferative Diabetic Retinopathy for treatment tailoring possibility. 
J. Vrzalova, M. Kozova, S. Rusnak, R. Ricarova, O. Topolcan 
Immunoanalytic Laboratory and Eye Department of University Hospital and Medical Faculty in Pilsen, E. 
Benese 13, 305 99 Plzen, Czech Republic. 
 
MSCs as tools for restoring morphofunctional deficiency and modulating immune responses at the 
preclinical stage of T1D: milestones and handicaps. 
D.S. Kostyushev1, M.A. Paltsev2, S.V. Suchkov1, 3 
1I.M. Sechenov First Moscow State Medical University, Moscow, Russia; 2National Research Center 
“Kurchatov Institute”, Moscow, Russia; 3Moscow State Medical Dentistry University, Moscow, Russian 
 
Association of ACE I and FABP2 genes polymorphism in cases with Type-2 Diabetes mellitus in 
Northern India. 
F. Mahdi1, D. Banerjee1, N. Rizvi3, R. Sapkota2, S. Saxena3, N.A. Khan2, S.T. Raza1 
1Era’s Lucknow Medical College & Hospital, Lucknow, India; 2Baba Farid Institute of Technology, 
Dehradun, India; 3Amity Institute of Biotechnology, Amity University, Lucknow, India 
 
Nutrition of pacients  with Diabetes mellitus type 2 in relation with smoking adiction – survey post- 
monica 2008/2009 in Czech Republic. 
M. Galovcová, V. Adámková, R. Cífková, Z. Petržílková, J. Bruthans, V. Lánská 
Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech 
Republic 
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 Specialised Session 
Tailored Prevention:  
Traditional Medicine, Personalised Nutrition, Body Culture & Sport  
 
Lecture Hall B 
 
4:15 pm – 7:00 pm 
 
Chairmen: Prof. Dr. H. Boecker, University of Bonn, Germany 
 Prof. Dr. P. Roberti di Sarsina, Non-Conventional Medicine, High Council of 
Health, Ministry of Health, Italy 
 Speakers: 
 Prof. Dr. J. Ionescu, Research Department of the Spezialklinik Neukirchen, Germany; 
Department of Medical Nutrition, Donau-University Krems, Austria; Specialised 
Clinic Neukirchen, Germany. Personalized anti-inflammatory nutrition for atopic 
eczema and psoriasis patients.  
 Dr. P. Roberti di Sarsina, Non-Conventional Medicine, High Council of Health, 
Ministry of Health, Italy. Tailored prevention and individualised treatment by 
traditional medicine. 
 Dr. F. de Meester, DMF-PL, Gliwice, Poland. Innovative PsychoSomatic Markers 
for prediction, prevention and personalised treatment of non-communicable 
diseases" 
 Prof. Dr. G. Trovato, Catania University, Italy. Lifestyle in health and disease: 
Mediterranean diet as a paradigm of an EBM and PPPM approach. 
 Prof. Dr. K. Richter, Clinic for Psychiatry and Psychotherapy, Clinic Nuernberg & 
Faculty for social work, GSO University Nuernberg, Germany. Shift Work and 
Breast Cancer. 
  
Short oral presentations: 
 Dr. J. Kinkorova, Charles Univesity, Prague, Czech Republic, Health – NCP –Net. 
Health NCP of the Czech Republic. 
 Prof. Dr. H. Boecker, Radiological Clinic, University of Bonn, Germany. On the 
emerging role of neuroimaging in determining functional and structural brain 
integrity induced by physical exercise: impact for Predictive, Preventive, and 
Personalized Medicine. 
 Dr. T. Cesuroglu, Institute for Public Health Genomics, Maastricht University, The 
Netherlands. Implementation of Personalized Health Care in Health Services in 
the Context of Public Health Genomics – Looking for the Broader Picture.  
 Dr. N. Moiseeva, I Belenova, A. Kunin, The Voronezh N.N.Burdenko, State Medical 
Academy, Russia. Individual (personalized) caries prevention: strategy and tactics.  
 
Panel Discussion 
 
Moderator: Prof. Dr. J. G. Ionescu, Specialised Clinic Neukirchen, Germany  
Panellists:  
Dr. R. Bubnov, Clinical hospital, State Affairs Department of Administration of the President 
of Ukraine, Kiev, Ukraine
 Speakers
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Poster Overview: Prof. Dr. G. Trovato, Catania University, Italy, Editorial BOARD, The 
EPMA J. 
  Posters related to the topic: 
 
Predictive diagnostic value of biomarkers for Renal Failure in Medical Emergency Relationship of NGAL 
(Neutrophil Gelatinase Associated Lipocalin) with  underweightness and malnutrition. 
G.F. Martines, C. Pirri, F. Trovato, S. Toro, A. Tonzuso, G. Carpinteri, D. Catalano, G. Trovato 
MCAU e Diagnostica e Terapia Medica – Azienda Ospedaliero-Universitaria "Policlinico-Vittorio Emanuele", 
Università di Catania, Italy 
 
Tailored medical treatments in obesity. Adherence to the mediterranean diet promote a lower 
inflammatory profile and minor insulin resistance and lipid metabolic alterations. 
C. Pirri, F.M. Trovato, A. Tonzuso, A. Pennisi, F.G. Martines, G.M. Trovato, D. Catalano 
Department of Internal Medicine, Medical Diagnostics and Therapy, University of Catania, Italy 
 
Personalized nutritional approach as the core treatment for NAFLD. Greater adherence to mediterranean 
diet is a targeted prevention. 
F.M. Trovato, C. Pirri, A. Tonzuso, A. Pennisi, F.G. Martines, G.M. Trovato, D. Catalano 
Department of Internal Medicine, Section of Medical Diagnostics and Therapy, University of Catania, Italy 
 
AD36 human adenovirus seropositivity. A novel obesity biomarker associated with enhanced response to 
dietary interventions. 
G.M. Trovato1 , G.F. Martines, C. Pirri, F.M. Trovato, P. Pace, A. Tonzuso, A. Pennisi, S. Toro, D. Catalano 
1Department of Internal Medicine, Diagnostica e Terapia Medica, Facoltà di Medicina e Chirurgia, Università di 
Catania, Catania, Italy 
 
A predictive diagnostic serological biomarker of NAFLD AD37 human adenovirus as a putative causative 
factor. 
G.M. Trovato1, G.F. Martines1, C. Pirri1, F.M. Trovato1, A. Castro2, A. Garozzo2, D. Catalano1 
1Department of Internal Medicine, Diagnostica e Terapia Medica, Facoltà di Medicina e Chirurgia, Università di 
Catania, Catania, Italy; 2Department of Microbiological and Gynaecological Sciences, Facoltà di Medicina e 
Chirurgia, Università di Catania, Catania, Italy 
 
Predictive value of dominant nodule in Hashimoto Thyroiditis. A clue for a personalized approach for 
greater risk of Papillary Thyroid Carcinoma. 
G. Trovato, P. Amico, G.F. Martines, M. Castaing, A. Torrisi, G.M. Vecchio, L. Salvatorelli, D. Catalano, G. 
Magro 
Department G.F. Ingrassia, Anatomic Pathology, and Department of Internal Medicine, Diagnostica e Terapia 
Medica, "University of Catania, Catania, Italy 
 
Uro-fecal disorders and dyspraxia. fMRI as an useful tool for personalized medicine. Preliminary results. 
B. Ventimiglia, A. Tsirgiotis, S. Motta, T. Puglisi, G. Trovato 
European Neurosciences Study Group, Servizio di Neuro Urologia ed Urodinamica Dipartimento delle Specialità 
Medico Chirurgiche, Università di Catania, Italy 
 
Ayurveda, the Paradigm for Personalized Medicine. 
A. Morandi1,2, C. Tosto1, D. Dalla Libera1,2,3 
1Ayurvedic Point, C.so Sempione 63, 20149 Milan, Italy; 2SSIMA, Italian Scientific Society for Ayurvedic 
Medicine, C.so Sempione 63, 20149 Milan, Italy; 3IRCCS San Raffaele, DIMER, Dept of Neurology, Via 
Olgettina 48, 20132 Milan, Italy 
 
Salutogenesis and Ayurveda: Indications for Public Health Management. 
A. Morandi1,2, D. Dalla Libera1,2,3 
1Ayurvedic Point, C.so Sempione 63, 20149 Milan, Italy; 2SSIMA, Italian Scientific Society for Ayurvedic 
Medicine, C.so Sempione 63, 20149 Milan, Italy; 3IRCCS San Raffaele, DIMER, Dept of Neurology, Via 
Olgettina 48, 20132 Milan, Italy 
 
Gknowmix.Com: A Gateway to Genomic Healthcare. 
M.J. Kotze, C. Watt, T. Janse van Rensburg, T. Bunn 
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 Department of Pathology, University of Stellenbosch, Tygerberg, South Africa 
 
Personality`s Profiles of teenagers and students: A comparative study performed in Timisoara, Romania. 
Cristina Petrescu1, Oana Suciu1, Sorin Ursoniu1, Brigitha Vlaicu1 
“Victor Babes” University of Medicine and Pharmacy, Timisoara, Romania 
 
Economic concerns about global healthcare: meeting the economic challenge of predictive, preventive, and 
personalized medicine. 
C. Ausweger1, E. Burgschwaiger1, A. Kugler1, R. Schmidbauer1, I. Steinek1, Y. Todorov1, D. Thurnher2, K. 
Krapfenbauer 2, 3  
1University of Economics and Business, Althanstrasse 14, A-1090 Vienna, Austria; 2Department of 
Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Waehringer Guertel 18-20, A-
1090 Vienna, Austria; 3European Association for Predictive, Preventive & Personalised Medicine, Brussels, 
Belgium 
 
 
Influence of fluorescence and electromethry in estimated characteristic and remineralization therapy of 
teeth. 
N.S. Moiseeva 
Voronezh N.N. Burdenko State Medical Academy, Studencheskaya str., 10, 394000, Voronezh, Russia 
 
Can pain management protocol be evidence based, physiological, safe and personalized? Integrated 
concept. 
R.V. Bubnov 
The Center of ultrasound diagnostics and interventional sonography, clinical hospital “Pheophania” of State 
Affairs Department, Kyiv, Ukraine  
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4th Congress-Day, September 18th, Sunday 
Venue: University Bonn, Poppelsdorf, Nußallee 10 
 
 
 
 
 
 
Plenary Lecture: 
Dr. S. Srivastava, EDRN, NIH / NCI, USA 
 
Lecture Hall A 
9 am – 9:45 am 
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 Specialised Session 
 
Biomarker Discovery  
Validation, Standardisation & 
Practical Application in Medical Practice 
 
Lecture Hall A 
 
10:00 am - 1:00 pm 
Chairmen:   Prof. Dr. M. Ferrari, Centre for Genomics, Bioinformatics, and Biostatistics,  
San Raffaele Scientific Institute, Milan, Italy 
Prof. Dr. J. Kzhyshkowska, Medical Faculty Mannheim, University of Heidelberg,  
Germany 
Speakers: 
 Prof. Dr. I. Gozes, Department of Human Molecular Genetics and Biochemistry, 
Sackler School of Medicine, Israel. Preventive, Predictive, Personalized and 
Participatory Healthcare Impacted by Climate, Culture and Community in the 
Computerized World.  
 Prof. W. Lieb, Institute for Community Medicine, Ernst Moritz Arndt University 
Greifswald, Germany. Approach to Individualized Medicine – (GANI_MED) – 
Standardisation of clinical data for research use. 
 Dr. Th. Joos, NMI Natural and Medical Sciences Institute at the University of 
Tübingen, Germany. Immunoassays in multiplex for biomarker discovery and 
validation. 
 Dr. T. Waerner, Dr. K. Krapfenbauer, Boehringer-Ingelheim RCV GmbH & CoKG, 
Vienna, Austria. The role of laboratory medicine in healthcare: Quality 
Requirements of immunoassays, standardisation and data management in 
prospective medicine. 
 Short oral presentations: 
 Dr. E. Moiseeva, Institute of Bioorganic Chemistry, Moscow, Russia. The “4s” 
concept: How to augment the predictive value of preclinical research.  
 Dr. M. Pilugina, Krasnoyarsk State Medical University named after Prof. V.F .Vojno-
Jasenetsky, Russia. Role of Laboratory Testing of Polymorphic Allele Variants of 
Gene CYP2C9 of Isoenzyme 2С9 of Cytochrome Р450 in Predictive, Preventive 
and Personalised Medicine on Epileptology. 
 Dr. P. Schulz-Knappe, Protagen AG, Dortmund, Germany. Autoantibody 
Biomarkers for Prostate Cancer Detection.  
 Dr. J. Vrzalova, Immunoanalytic laboratory, Faculty Hospital and Faculty of Medicine 
in Pilsen, Charles University in Prague, Czech Republic. Multiplex x MAP analysis – 
analytical tool for personalised medicine. 
 Dr. J. Walkenhorst, PROvendis, Germany. Knowledge Transfer and Patenting 
Strategy in Predictive Medicine.  
 Panel Discussion  
Moderator: Dr. Ph. Jacon, Director General, European Diagnostic Manufacturers 
Association, EDMA  
 Panellists 
Dr. G. Grech, Department of Pathology, University of Malta, Malta 
Speakers 
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Poster Overview: Dr. K. Krapfenbauer, Boehringer-Ingelheim RCV GmbH, Austria 
 
Posters related to the topic: 
 
Systematic Development of Novel Antibody Biomarkers for Diagnostic Protein. 
A. Lueking1, A. Kowald1, G. Bartsch2, H. Klocker2, H. Göhler1, P. Amersdorfer1, S. Muellner1, P. Schulz-
Knappe1 
1Protagen AG, Dortmund, Germany; 2Dept. of Urology, Innsbruck Medical University, Austria 
 
Evaluation of the Immunization Strategy Implementation in the Republic of Macedonia for the period 
2004 – 2009. 
N. Kamchev1, M. Zdravkovska2, V. Ivanovska1, G. Kamcheva1 
1Faculty of Medical Sciences, University Goce Delcev, Stip, Republic of Macedonia; 2Medical Faculty, 
University Ss. Cyril and Methodius, Skopje, Republic of Macedonia 
 
Reproducibility of 3-Part Differential Hematology Analyzer Medonic CA620: a study after 3 years and 90 
000 samples. 
T. Ruskovska, N. Kamcev, G. Kamceva, N. Siljanovski 
Faculty of Medical Sciences, University “Goce Delcev”, Stip, Macedonia 
 
Activity of Antiseptic Solutions in relation to their physicochemical properties. 
B. Gjorgjeska, C. Dimova 
Faculty of Medical Sciences, Krste Misirkov bb, POB 201, 2000 Stip, Republic of Macedonia 
 
Level of unsaturation of fatty acids in biodiversal biomasses and extracts: rapid assessment with FT-IR. 
T.A. Egorova-Zachernyuk1, A.M.A. Pistorius2, W. J. DeGrip2 
1Protein Labelling Innovation (PLI), BioScience Park, Archimedesweg 27 2333 CM Leiden, The Netherlands; 
2Nijmegen Centre for Molecular Life Sciences (NCMLS), RUNMC, P.O. Box 9101, NL-6500 HB Nijmegen, 
The Netherlands 
  
Measurement of isotope enrichment in stable-isotope labeled biomasses and extracts: rapid assessment 
with FT-IR. 
T.A. Egorova-Zachernyuk1, A.M.A. Pistorius2, W. J. DeGrip2 
1Protein Labelling Innovation (PLI), BioScience Park, Archimedesweg 27 2333 CM Leiden, The Netherlands; 
2Nijmegen Centre for Molecular Life Sciences (NCMLS), RUNMC, P.O. Box 9101, NL-6500 HB Nijmegen, 
The Netherlands 
  
Cost-effective stable isotope labelling of drug targets and protein therapeuticals in insect and mammalian 
cell lines  
T. A. Egorova-Zachernyuk1, W. J. DeGrip2 
1Protein Labelling Innovation (PLI), BioScience Park,  Archimedesweg 27 2333 CM Leiden, The Netherlands;  
2Department of Biochemistry, NCML, Radboud University Medical Centre (RUNMC) P.O. Box 9101, NL-6500 
HB Nijmegen, The Netherlands 
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 Specialised Session 
 
Patient-specific Modelling 
Bioinformatics in PPPM 
 
Lecture Hall B 
 
9:50 am - 11:20 am 
 
Chairmen:  Prof. Dr. H. Lemke, Computer Assisted Radiology and Surgery, CARS 
  Dr. M. Kapalla, Negentropic Systems, s.r.o., Ruzomberok, Slovakia 
Speakers: 
 
 Prof. Dr. H. Lemke, University of Southern California, Los Angeles, USA. Medical 
and information technology aspects for personalised medicine. 
 Prof. Dr. L. Berliner, Weill Cornell Medical College of Cornell University, New York, 
USA. Patient specific modelling and model guided therapy. 
 Dr. M. Kapalla, Negentropic Systems, s.r.o., Ruzomberok, Slovakia. Interpretation 
of laboratory results in the complex predictive diagnostics: status quo and 
perspectives. 
 Dr. A. Shabo, IBM Research Lab in Haifa, Israel. Meaningful use of patient-centric 
health records for personalized medicine. 
 Dr. M. Marcus-Kalish, Interdisciplinary Center for Technology Analysis and 
Forecasting, Tel Aviv University, Israel. Multilevel, Multisource Bio- Medical rule 
discovery system – essential enabler to preventive, predictive and personalized 
medicine. 
 Prof. Dr. H. Podbielska, Wroclaw University of Technology, Poland. Computer-
assisted modelling of ocular parameters for personalized treatment in 
ophthalmology.  
 
Panel Discussion 
Moderator: Prof. Dr. H. Podbielska, Wroclaw University, Poland 
 
Panellists: 
Speakers 
 
Posters related to the topic 
 
Question of choise, decision making in diagnostic imaging and intervention mistake prediction. 
Mathematical modeling approach. 
R.V. Bubnov1 , I.M. Melnyk2 
1The Center of ultrasound diagnostics and interventional sonography, clinical hospital “Pheophania” of State 
Affairs Department, Kyiv, Ukraine; 2International Research and Training Center for Information Technology 
and Systems NAS and MES of Ukraine, Kyiv, Ukraine 
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Specialised Session 
 
Bio-Banking  
Ethics 
 
Lecture Hall B 
 
11:30 pm – 1:00 pm 
 
Chairman:  Prof. Dr. R. Hewitt, European, Middle Eastern and African Society for  
 Biopreservation and  Biobanking, France 
 
 Prof. Dr. R. Hewitt, European, Middle Eastern and African Society for 
Biopreservation and  Biobanking, France. The European, Middle-Eastern and 
African Society for Biopreservation and Biobanking (ESBB): Current status and 
plans for the future. 
 Prof. Dr. P Riegman, Erasmus MC Tissue Bank, Erasmus MC Rotterdam, The 
Netherlands. Biobanking access rules and exchangeability in multi center medical 
research networks. 
 Prof. Dr. Ch. Chabannon, Institut Paoli-Calmettes & Université d’Aix-Marseille, 
France. Hospital organization to provide access to samples and clinical data for 
translational and clinical research in oncology.  
 Prof. Dr. P. Hofman, Nice CHU Biobank, Pasteur Hospital, Nice, France. Experience 
of collecting patient informed consent for research use of biospecimens in the 
Nice Chu Biobank, a member of the Canceropôle Paca Biobank Network. 
 Prof. Dr. H. Everaus, Tartu University Hospital, Tartu, Estonia, Ethical aspects of 
personalized medicine. 
 
Panel Discussion 
Moderator: Prof. Dr. H. Everaus, Tartu University Hospital, Tartu, Estonia 
 
 
Panellists: 
Speakers 
Dr. Leitsalu, University of Tartu, Tartu, Estonia 
 
Poster Overview: Prof. Dr. H. Everaus, Tartu University Hospital, Tartu, Estonia 
 
Posters related to the topic: 
 
Making the link: biobank and medicine. 
L. Leitsalu1, A. Metspalu1,2,3 
1Estonian Genome Center, University of Tartu, Tartu, Estonia; 2Institute of Molecular and Cell Biology, 
University of Tartu, Tartu, Estonia; 3Estonian Biocentre, Tartu, Estonia 
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Awarding Ceremony:  
A Prize for Best Poster Presentation by The EPMA J 
 
Closing Ceremony 
Lecture Hall A 
1:15 am – 1:45 am 
 
 
 
Lunch: 1:45 pm – 2:30 pm 
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